Paysign (NASDAQ:PAYS) Stock Sees Heavy Call Option Buying

Paysign, Inc. (NASDAQ:PAYS) was the recipient of unusually large options trading activity on Wednesday. Traders bought 2,581 call options on the company. This is an increase of approximately 712% compared to the typical volume of 318 call options.

Paysign Stock Down 6.5%

NASDAQ PAYS opened at $9.48 on Thursday. The stock has a market capitalization of $535.24 million, a PE ratio of 30.73 and a beta of 0.92. Paysign has a 12-month low of $3.08 and a 12-month high of $16.15. The company has a 50 day moving average price of $13.76 and a two-hundred day moving average price of $8.66.

Paysign (NASDAQ:PAYS) last announced its quarterly earnings results on Monday, November 9th. The company reported $0.11 EPS for the quarter, topping the consensus estimate of $0.09 by $0.02. The company had revenue of $30.80 million for the quarter, compared to analyst estimates of $29.02 million. Paysign had a net margin of 18.48% and a return on equity of 37.20%. As a group, equities analysts anticipate that Paysign will post 0.38 EPS for the current year.

Insider Buying and Selling

In other Paysign news, EVP Joan Herman sold 38,900 shares of Paysign stock in a transaction that occurred on Wednesday, September 16th. The shares were sold at an average price of $11.74, for a total transaction of $456,686.00. Following the transaction, the executive vice president directly owned 609,421 shares in the company, valued at approximately $7,154,602.54. The trade was a 6.00% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Michael Ngo sold 79,925 shares of the business’s stock in a transaction on Wednesday, September 9th. The shares were sold at an average price of $12.74, for a total transaction of $1,018,244.50. Following the sale, the insider directly owned 2,350,000 shares in the company, valued at approximately $29,939,000. This trade represents a 3.29% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last 90 days, insiders sold 259,904 shares of company stock valued at $3,402,424. Company insiders own 24.50% of the company’s stock.

Hedge Funds Weigh In On Paysign

Hedge funds have recently bought and sold shares of the business. Legal & General Group Plc bought a new position in Paysign during the second quarter valued at about $35,000. EFG International AG bought a new stake in shares of Paysign during the 2nd quarter worth about $68,000. Quantbot Technologies LP bought a new stake in shares of Paysign during the 2nd quarter worth about $97,000. The Manufacturers Life Insurance Company bought a new stake in shares of Paysign during the 2nd quarter worth about $100,000. Finally, Tidal Investments LLC acquired a new position in shares of Paysign during the 2nd quarter valued at about $121,000. 25.89% of the stock is owned by institutional investors and hedge funds.

Top Paysign Stories

Here are a few of the latest stories about PAYS:

• Positive Sentiment: Ladenburg Thalmann raised its price target to $15.25 from $14.00 and reiterated a Buy rating. Ladenburg Thalmann ratings
• Neutral Sentiment: DA Davidson lowered its target to $14 from $15 but maintained a Buy rating, suggesting its outlook remains positive despite a reduced valuation estimate. DA Davidson ratings
• Negative Sentiment: Maxim Group downgraded Paysign from Buy to Hold, adding to concerns about the shares’ near-term prospects. Maxim Group ratings

Analyst Upgrades and Downgrades

A number of brokerages have commented on PAYS. Ladenburg Thalmann & Co. Inc. raised their price objective on Paysign from $14.00 to $15.25 and gave the stock a “buy” rating in a research report on Wednesday. Weiss Ratings upgraded Paysign from a “buy (b-)” rating to a “buy (b)” rating in a report on Thursday, October 8th. DA Davidson dropped their target price on Paysign from $15.00 to $14.00 and set a “buy” rating on the stock in a report on Wednesday. Wall Street Zen lowered shares of Paysign from a “strong-buy” rating to a “buy” rating in a research report on Sunday, August 16th. Finally, Lake Street Capital boosted their price objective on shares of Paysign from $13.00 to $15.00 and gave the company a “buy” rating in a research report on Tuesday, September 15th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. According to MarketBeat.com, Paysign has a consensus rating of “Moderate Buy” and a consensus target price of $14.81.

Paysign Company Profile

Paysign, Inc. provides prepaid card programs, payment processing and related financial technology services. Its platform supports organizations that need to distribute funds and manage payments, including businesses in the healthcare sector. The company serves plasma collection centers with donor compensation and payment solutions, and works with pharmaceutical companies on patient assistance and affordability programs. Its services also support payments for clinical trials and other disbursement needs.